Related Experiment Video
Updated: May 16, 2026
06:05
An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
Published on: March 9, 2022
[MITO-Porter; a cutting-edge technology for mitochondrial gene therapy]
Ryo Furukawa1, Yuma Yamada, Hideyoshi Harashima
1Laboratory for Molecular Design of Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan. furukawa-ryo@mail.sci.hokudai.ac.jp
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|December 5, 2012
Summary
Gene therapy can target mitochondrial DNA (mtDNA) to treat mitochondrial diseases. A novel MITO-Porter system effectively delivers therapeutic cargo into mitochondria, offering a promising strategy.
Area of Science:
- Mitochondrial biology and gene therapy
- Molecular medicine and genetic disorders
Context:
- Mitochondrial DNA (mtDNA) mutations cause severe diseases.
- Therapeutic strategies require efficient delivery to the mitochondrial matrix.
- Current mitochondrial transfection methods are limited.
Purpose:
- To review advancements in mitochondrial gene therapy.
- To highlight the potential of the MITO-Porter delivery system.
- To discuss the application of MITO-Porter for delivering therapeutic agents to mitochondria.
Summary:
- The MITO-Porter, a liposomal nanocarrier, facilitates the delivery of chemical compounds and proteins into the mitochondrial matrix via membrane fusion.
- This system enables the pharmacological enhancement of lecithinized superoxide dismutase (PC-SOD) and supports the transcription activation of exogenous DNA by mitochondrial transcription factor A (TFAM).
- The review explores the potential of MITO-Porter as a universal mitochondrial targeting device.
Impact:
- Provides a novel delivery system for mitochondrial gene therapy.
- Offers a potential therapeutic approach for a range of mitochondrial diseases.
- Advances the development of targeted therapies for genetic disorders affecting mitochondria.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
02:59Animal Mitochondrial Genetics
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
02:19Export of Mitochondrial and Chloroplast Genes
A eukaryotic cell can have up to three different types of genetic systems: nuclear, mitochondrial, and chloroplast. During evolution, organelles have exported many genes to the nucleus; this transfer is still ongoing in some plant species. Approximately 18% of the Arabidopsis thaliana nuclear genome is thought to be derived from the chloroplast’s cyanobacterial ancestor, and around 75% of the yeast genome derived from the mitochondria’s bacterial ancestor. This export has occurred irrespective...
01:39Mitochondrial Precursor Proteins
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial precursors...
Most of the mitochondrial precursors...
01:19Translocation of Proteins into the Mitochondria
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...